These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19476109)

  • 1. Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS).
    Hermans MP; Van Mieghem W; Vandenhoven G; Vissers E
    Acta Cardiol; 2009 Apr; 64(2):177-85. PubMed ID: 19476109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.
    Wang KF; Chang CC; Wang KL; Wu CH; Chen LC; Lu TM; Lin SJ; Chiang CE
    J Chin Med Assoc; 2014 Feb; 77(2):61-7. PubMed ID: 24332414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).
    Chiang CE; Ferrières J; Gotcheva NN; Raal FJ; Shehab A; Sung J; Henriksson KM; Hermans MP
    J Atheroscler Thromb; 2016 May; 23(5):567-87. PubMed ID: 26632163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries.
    Hermans MP; Castro Cabezas M; Strandberg T; Ferrières J; Feely J; Elisaf M; Michel G; Sansoy V
    Curr Med Res Opin; 2010 Feb; 26(2):445-54. PubMed ID: 20001658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey.
    Elisaf MS; Nikas N
    Angiology; 2010 Jul; 61(5):465-74. PubMed ID: 20462896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pan-European survey on the undertreatment of hypercholesterolemia in hypolipidemias(Luxembourg)].
    Michel G; Muller P
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):509-16. PubMed ID: 19024370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
    Ferrières J; Gousse ET; Fabry C; Hermans MP;
    Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.
    Hammoudeh AJ; Echtay A; Ghanem GY; Haddad J;
    Curr Med Res Opin; 2014 Oct; 30(10):1957-65. PubMed ID: 24889279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
    Shalev V; Goldshtein I; Halpern Y; Chodick G
    Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy.
    Presta V; Figliuzzi I; Miceli F; Coluccia R; Fogacci F; Cicero AFG; Ferrucci A; Borghi C; Volpe M; Tocci G;
    Atherosclerosis; 2019 Jun; 285():40-48. PubMed ID: 31003091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.
    Raal F; Schamroth C; Blom D; Marx J; Rajput M; Haus M; Hussain R; Cassim F; Nortjé M; Vandehoven G; Temmerman AM
    Cardiovasc J Afr; 2011; 22(5):234-40. PubMed ID: 21922121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
    Thompson GR; Catapano A; Saheb S; Atassi-Dumont M; Barbir M; Eriksson M; Paulweber B; Sijbrands E; Stalenhoef AF; Parhofer KG
    Curr Opin Lipidol; 2010 Dec; 21(6):492-8. PubMed ID: 20935563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
    Ho LT; Yin WH; Chuang SY; Tseng WK; Wu YW; Hsieh IC; Lin TH; Li YH; Huang LC; Wang KY; Ueng KC; Fang CC; Pan WH; Yeh HI; Wu CC; Chen JW;
    PLoS One; 2015; 10(3):e0116513. PubMed ID: 25756522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.